Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report

Abstract In Brazil, meglumine antimoniate is the first drug of choice for mucosal leishmaniasis treatment followed by amphotericin B and pentamidine isethionate. We report the case of a patient with severe mucosal lesions caused by Leishmania (Viannia) braziliensis that were difficult to treat. Over a 14-year period, the patient showed low adherence and three treatment attempts with meglumine antimoniate failed. Additionally, there was an unsatisfactory response to liposomal amphotericin B and nephrotoxicity when using amphotericin B deoxycholate that persisted after new treatment attempt with liposomal amphotericin B. Finally, healing was achieved with pentamidine isethionate and maintained during nine months of monitoring.

Bibliographic Details

Main Authors:	Ferreira Terceiro,Benivaldo Ramos, Torraca,Tania Salgado de Souza, Braga,Frederico Pereira Bom, Martins,Ana Cristina da Costa, Brahim,Lucia Regina, Saheki,Mauricio Naoto, Miranda,Luciana de Freitas Campos, Schubach,Armando de Oliveira, Valete-Rosalino,Cláudia Maria
Format:	Digital revista
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical - SBMT 2019
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100700
Tags:	Add Tag No Tags, Be the first to tag this record!